Daily news email for October 01, 2014 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution as Director and Senior Scientific Advisor to ...

KBI Biopharma Acquires Biologics Operations in Colorado

Lophius Biosciences Secures EUR 2,0 Million Financing and Announces Leadership Changes

Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG

Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining as CFO/CBO to ...

FDA Slams Sun Pharmaceutical Industries Ltd For Continued Violations At Plant

Planes Can Harbor Deadly Germs For 7 Days, Auburn University Study

Fremont-Based Ardelyx Inc. Files For $69 Million IPO

Can AstraZeneca PLC Live Up To CEO's Growth Plans

Anti-Bacterial Agent Found In Most Hand Soaps Banned In Minnesota

BioSpace - Breaking News
Boehringer Ingelheim Corporation Presents First Phase 3 Data On Fixed-Dose Combination Of Tiotropium Plus Olodaterol In COPD

Baxter International, Inc. Provides U.S. Regulatory Update On Hyqvia, Its Investigational Subcutaneous Treatment For Primary Immunodeficiency

Novo Nordisk A/S: FDA Schedules Advisory Committee Meeting For Liraglutide 3 Mg For The Treatment Of Obesity

Antibe Therapeutics Inc. Announces Submission Of Clinical Trial Application To Health Canada For ATB-346

AbbVie Receives Orphan Drug Designation For HUMIRA® (Adalimumab) From The FDA For The Investigational Treatment Of Certain Forms Of Non-Infectious Uveitis

Biotech News - Business Wire
Targeted Medical Pharma Looks to China as the Next Medical Food Market

Targeted Medical Pharma Reports First Quarter 2014 Financial Results

Definitive Merger Plan between BioAlliance Pharma and Topotarget


Medical Genetics Specialty Board Changes Name

Biotech News - PR Newswire
Oncolytics Biotech® Inc. Announces Nomination of Two New Directors

CannaVest veröffentlicht finanzielle Eckdaten zum ersten Quartal 2014

Sinovac Reports Unaudited First Quarter 2014 Financial Results

Venaxis to Participate in 11th Annual Craig-Hallum Institutional Investor Conference

Kindred Bio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Pfizer Ups Offer for AstraZeneca to $119B

FDA Rejects Novartis Serelaxin for Acute Heart Failure

Abbott Buys Chile's CFR Pharmaceuticals for $2.9B

Shedding Non-Core Assets

Expanding the Building Blocks of DNA

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results on March 13, 2013 at 8:30 AM E.T.

Research and Markets: Thromboembolism Global Clinical Trials Review, H1, 2013

RegeneRx Receives Notice of Allowance for 2nd U.S. Heart Patent

Trevena to present results of TRV027 Phase 2a Study in Patients with Advanced Heart Failure

Clinical Trials - PR Newswire
Uno studio di follow-up di 8 anni di recente pubblicazione conferma la sicurezza, l'efficacia e la durabilità della terapia Stretta nel trattamento della MRGE

ClearWay Minnesota(SM) announces new research grants

Estudio de seguimiento de 8 años publicado recientemente confirma la seguridad, eficacia y durabilidad de Stretta en el tratamiento de GERD

O estudo recentemente publicado de 8 anos de seguimento confirma a segurança, eficácia e durabilidade da terapia Stretta no tratamento da DRGE

Evaluating 'Acquired Immunity' May Improve Estimates Of Infectious Disease Risk

CNN Top Stories
7 DUIs get entrepreneur work release

Sinkhole opens at football stadium

Truck with millions of bees wrecks

Boston bombs 'difficult to build'

Boston bombing evidence

Contract Pharma
GlycoMimetics Receives $15M Pfizer Milestone

WuXi PharmaTech Tox Facility Passes Belgium Inspection

Hemispherx, GP Pharm to Establish Mfg. Ops in Argentina

Relypsa, DSM Enter API Supply Pact

SGS Makes Key Appointments For New CA Facility

FDA Drugs- What's New
Safe Use Initiative

Comunicado de la FDA sobre la seguridad de los medicamentos: Estudio de la FDA de pacientes de Medicare encontró menor riesgo de derrame cerebral y muerte con Pradaxa (dabigatrán) en comparación con warfarina

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose

FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin

FDA permits manufacturers of oral health care benzocaine products to include a methemoglobinemia warning

FDA News - Business Wire
AtriCure Announces First Patient Enrolled in Stroke Feasibility Study

Cardiovascular Systems to Feature Late-Breaking Coronary Data at SCAI 2014 Scientific Sessions

DIA Executive Program Session to Examine Impact of Industry Shift to Targeted Therapies

Cogmedix Selected to Manufacture Convergent Dental's Revolutionary CO2 Laser System

Direct Flow Medical, Inc. Announces IDE Approval for U.S. Pivotal Trial

FDA Press Releases
FDA approves first molecular (gene-based) test to determine red blood cell types in transfusion medicine

FDA approves Entyvio to treat ulcerative colitis and Crohn's disease

U.S. Marshals seize unapproved drugs from Ohio distributor

FDA requiring lower starting dose for sleep drug Lunesta

FDA allows marketing of first prosthetic arm that translates signals from person’s muscles to perform complex tasks

FDA Vaccines, Blood and Biologics - What's New
Officer/ Employee List for STN 125478/0, RAGWITEK

Summary Basis for Regulatory Action - ALPROLIX

CBER FY 2013 Recall Posting

Draft Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies.

Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus

Wilex hands back some cancer drugs as it circles the biotech drain

Shire heads to the FDA with its dry eye drug despite a so-so PhIII

AstraZeneca partner Ardelyx pitches $69M IPO

Swelling ranks of AstraZeneca's dissident shareholders press for a Pfizer deal

Gene therapy upstart bags a $22M A round for neurodegenerative work

FierceBiotech IT
Takeda inks $400M IT services deal with Wipro

EMA criticized for flip-flopping on clinical trial data transparency

Paypal co-founder backs genomics data access startup

Venter nabs AstraZeneca's R&D IT chief for Human Longevity

Bayer, Boehringer extend access to clinical trial data

FierceBiotech Research
Nanocarriers that harness fungus traits could deliver drugs to brain

CDC scientist: MERS doesn't present pandemic risk, but other diseases might

Animal model that mimics hep B, C in humans could spur new therapies

Anti-MERS therapies IDed among existing drugs

Natural antibacterial clay could fight MRSA, other infections

Three launches this year just the beginning of Teva turnaround, CEO says

FDA officials say they're 'serious' about pharma's free speech

Jury's out in Las Vegas after 3-month trial over Actos cancer risks

Top payer group shoots down Gilead's hep C drug Sovaldi on price

Second-line use, crowded market won't keep Takeda's Entyvio from blockbuster run

FiercePharma Manufacturing
Merck KGaA's 50M investment in Italy will help it fill biologics demand

FDA warning letter says Sun Pharma plant hid batch failures

FDA balks at accepting all EU plant inspections

Manufacturing continues to boost WuXi PharmaTech sales

Abbott expands manufacturing in Latin America with CFR deal

CIA abandons use of vaccine programs for spying

Kymab, Gates Foundation to team up for malaria, HIV antigen discovery

Sanofi C. diff vaccine shows immune response in PhII trial

Mayo Clinic: Massive dose of measles vax killed cancer

Computer model can boost child vaccination rates while cutting costs

Health News - BizJournals.com
Triad BioNight honors five for innovation, entrepreneurship, leadership

Turnabout: Insurance chief orders investigation of whistleblower judge

Phoenix water bill hikes could pinch some businesses as city looks for $11M

CEO of nursing care provider admits embezzling $600,000

CFPB finds medical debt factoring into creditworthiness

Health News - CNBC
Germany's Merck Serono to produce medicines in UAE

Germany's Merck Serono to produce medicines in UAE

Analysis: Drugmakers step up search for hearing loss medicines

Grand jury probing meningitis-linked pharmacy: newspaper

Small Employers Weigh Impact of Providing Health Insurance

Health News - Fox Business
AstraZeneca Rejects Pfizer's 'Final' Buyout Offer

Pfizer to Submit New Application for Breast Cancer Drug

AstraZeneca Touts Cancer Pipeline as Pfizer Battle Intensifies

Eli Lilly Loses UK Alimta Patent Case To Actavis

Merck Sells Japan Eye-Treatment Rights for $600M

Inside Industry - Gen
McKesson's $8.3B Celesio Deal Builds Drug Warehousing Powerhouse

DSM, Sanquin Make Factor IX-Recovering mAb Manufacturing Deal

Startup Wins Five-Year Exclusive License to deCODE Genetics Platform

Cleveland BioLabs Subsidiary Awarded $4.6M Russian Contract

Imugene Acquiring Biolife, as Lead Pipeline Candidate Nears Phase II

Marketwire - Pharma and Biotech
Santhera Reports Positive Outcome for Catena(R)/Raxone(R) in Phase III DMD Trial Supported by Additional Respiratory Function Data

RepliCel Life Sciences Inc. Announces Closing of Second Tranche of Private Placement

Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.

Theravance to Present at the Jefferies 2014 Healthcare Conference

NOVADAQ Reports Voting Results From Annual and Special Meeting of Shareholders

MassBio News
MassBio Welcomes Five New Board Members

Collaborative models and IPO window are hot topics at BioPharm America 2014 program

Leominster is BioReady®

Cambridge-Boston-Quincy-Somerville-Braintree Launch Life Sciences Corridor Initiative

SoPE & Harvard Business School Healthcare Alumni Association to Host Big Data - Opportunities in Healthcare

Medical Pharma - PR Newswire
Une étude de suivi à 8 ans récemment publiée confirme l'innocuité, l'efficacité et la durabilité de Stretta dans le traitement du RGO

Concord Medical Reports First Quarter 2014 Financial Results and Reiterates Full Year 2014 Earnings Guidance

Alere Inc. Announces Commencement of Consent Solicitation Related to its 7.250% Senior Notes due 2018, 8.625% Senior Subordinated Notes due 2018 and 6.500% Senior Subordinated Notes due 2020.

Home Health Leaders Commend Introduction of Post-Acute Care Reform Bill to Encourage Better Care Coordination, Patient Choice and Quality Care

CPhl, feira de ingredientes farmacêuticos, terá aplicativo e diretório que vão diminuir a distância entre compradores e fornecedores

National Center for Biotechnology Information
MedGen News

NCBI Announcements


NLM Catalog New and Noteworthy

PubMed Central News

Nature Biotechnology
HIV immunity goes direct

Rarefied drug pricing

Genentech to salvage anti-MET antibody with subgroup analysis

Fecal transplantation poses dilemma for FDA

Better than breakthrough scheme snags

New York Times- Biotechnology
Seeking Support, Biotech Food Companies Pledge Transparency

A High-Tech Menagerie

Cornell Scientist’s Quest: Perfect Broccoli

After Patent Ruling, Availability of Gene Tests Could Broaden

Connecticut Approves Labeling Genetically Modified Foods

New York Times- Pharmaceuticals
A Dry Pipeline for Psychiatric Drugs

Death Row Improvises, Lacking Lethal Mix

A Musical Switch From Self-Pity to Gratitude

Warning: This Pill May Be Dangerous to Your Health

To Judge Sleep Aids, U.S. Looks at Drowsy Driving in the Morning

OptiMedica, Corp.: Series E $35M

iRythm Technologies, Inc.: Series C $1.5M

Edison Pharmaceuticals, Inc.: Series F $20M

New Haven Pharmaceuticals, Inc.: Series A $6.6M

Kiadis Pharma, B.V.: Series D $12.8M

Consolidation prevalent in industry, says third largest CMO

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Consolidation prevalent in industry, says third largest CMO

Patheon and DSM crossover limited, more growth targeted says DPx

Pharma News - Business Wire
Targeted Medical Pharma Reports First Quarter 2014 Financial Results

AHF: Insurers Say Gilead's Sovaldi Pricing Not Sustainable

Voluntary Nationwide and Canada Recall of NaturaLyte® Liquid Bicarbonate Concentrate Due to Potential Health Risk

Definitive Merger Plan between BioAlliance Pharma and Topotarget


Pharma News - PharmiWeb
ZirMed Acquires Intelligent Healthcare

As College Graduates Celebrate, ValueOptions Offers Tips for Students to Take Control of Their Mental Health

Singulex Appoints Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer

Antibe Therapeutics Announces Submission of Clinical Trial Application to Health Canada For ATB-346

Avaxia CEO Barbara Fox is Named an EY Entrepreneur Of The Year 2014 Award Finalist in New England

Pharma News - PR Newswire
PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

Pegasus Legal Funding Offers Funding to Victims and Families Affected by Pharmaceutical Drug Recalls

Cognition Therapeutics' Small Molecule Soluble Abeta Oligomer Receptor Antagonist Program for Alzheimer's Disease Selected for Support by National Institute on Aging/NIH Cooperative Agreement Program

Parnell Pharmaceuticals Files Registration for Proposed Initial Public Offering

Global Lecithin & Phospholipids Market by Source (Soy, Sunflower, Egg), by Application (Food, Nutrition & Supplements, Cosmetics, Feed, Pharmaceuticals) - Forecasts to 2019

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Trevigen Inc. Awarded Prestigious Grant to Bring CometChip™ to Market

Netrepid To Present Hosted Video Surveillance Solutions With LowV Systems At INTERPHEX 2014

CPSI Biotech Welcomes Congressman Reed

CPSI Biotech Awarded the 2013 Tibbetts Award for Technological Innovation and Impact

Pearl River, New York, Author Publishes New Book for Children about Mental Illness

PRWeb - Biotechnology
Neural ID Releases IWS Version 2.4 to Support Preclinical Cardiac...

Nutrex Hawaii Launches Powerful Green Complete SuperFood Powder,...

Texas Groundwater Conservation Districts Are Saving Time and Money...

Convoy Therapeutics to Attend BIO International

DNA Test Price Reductions Generate a Win for Consumers

PRWeb - Pharmaceuticals
Health Leadership Education Programs Published by Dove Medical Press

Every Woman's Hot Flash Experience is Entirely Different and Unique

Biosimilars Market Future Discussed in New Research Report by...

The Cancer Drugs & Treatments Market - Data, Analysis &...

Clinverse, Inc. Announces Strategic Partnership with eClinical...

Scientific American
Neurofeedback Increases Affection, Builds Empathy

Backlash to Big Bang Discovery Gathers Steam

How Bacteria in Placenta Could Help Shape Human Health

For Atom-Friendly Asia, a Nuclear Power Boomin the West, Stagnation

For Atom-Friendly Asia, a Nuclear Power Boonin the West, Stagnation

Sports - ESPN Basketball
Michigan St.'s Byrd transferring to NAIA school

Jayhawks bring on 6-8 Mykhailiuk of Ukraine

Bilas/Goodman: Top head coach candidates

Panel formed at Oregon after dismissal of 3

Auburn lands Ross-Miller from New Mexico State

Sports News - ESPN
BYU investigating alleged improper benefits

Slive: Autonomy to be focus of SEC meetings

Sources: Tide's Thomas to headline HOF class

Schlabach: Scheduling for a playoff

Coaches Weigh In On Scheduling Changes

Xconomy Life Sciences
Radius Health Recharges IPO After Two Week Hiatus

Science and Art: Why Choose A Biotech Entrepreneur's Dual Life

Boston 2034: The Big Agenda for Our June 10 Innovation Conference

1Q VC Data: What Just Happened

ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)